Celiac disease and endocrine autoimmune disorders in children: an update

References

• Husby S, Koletzko S, Korponay-Szabó IR et al. ESPGHAN Working Group on Coeliac Disease Diagnosis, on behalf of the ESPGHAN Gastroenterology Committee European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Guidelines for the Diagnosis of Coeliac Disease. J. Ped. Gastroenterol. Nutr. 54(1), 136–160 (2012).
   PubMed Web of Science ®Google Scholar
• Reilly NR, Fasano A, Green PH. Presentation of celiac disease. Gastrointest. Endoscopy Clin. N. Am. 22, 4 613–621 (2012).
   PubMedGoogle Scholar
• Kumar V, Rajadhyaksha M, Wortsman J. Celiac disease-associated autoimmune endocrinopathies. Clin. Diagn. Lab. Immunol. 8, 4 678–685 (2001).
   PubMedGoogle Scholar
• Bai D, Brar P, Holleran S, Ramakrishnan R, Green PH. Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men. Scand. J. Gastroenterol. 40(2) 183–187 (2005).
   PubMedGoogle Scholar
• Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 117(2) 297–303 (1999).
   PubMedGoogle Scholar
• Sategna-Guidetti C, Solerio E, Scaglione N, Aimo G, Mengozzi G. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 49(4) 502–505 (2001).
   PubMedGoogle Scholar
• Study on correlation between the duration of exposure to gluten and risk of autoimmune disorders in celiac patients.Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84(3) 223–243 (1997).
   PubMedGoogle Scholar
• Viljamaa M, Kaukinen K, Huhtala H, Kyrönpalo S, Rasmussen M, Collin P. Coeliac disease, autoimmune diseases and gluten exposure. Scand. J. Gastroenterol. 40(4) 437–443 (2005).
   PubMedGoogle Scholar
• Cosnes J, Cellier C, Viola S et al. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin. Gastroenterol. Hepatol. 6(7) 753–758 (2008).
   PubMedGoogle Scholar
• Di Mario U, Anastasi E, Mariani P et al. Diabetes-related autoantibodies do appear in children with coeliac disease. Acta Paediat. 81(8), 593–597 (1992).
   PubMed Web of Science ®Google Scholar
• Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 10(1), 43–55 (2009).
   PubMed Web of Science ®Google Scholar
• Trynka G, Hunt KA. Bockett NA et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43(12), 1193–1201 (2011).
   PubMed Web of Science ®Google Scholar
• Smyth DJ, Plagnol V, Walker NM et al. Shared, distinct and opposing genetic factors in type 1 diabetes and celiac disease. N. Engl. J. Med. 359(26), 2767–2838 (2008).
   PubMed Web of Science ®Google Scholar
• Ide A, Eisenbarth GS. Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders. Rev. Endocr. Metab. Disord. 4(3), 243–253 (2003).
   PubMed Web of Science ®Google Scholar
• Barker JM. Clinical review: type 1diabetes-associated autoimmunity: natural history, genetic associations and screening. J. Clin. Endocrinol. Metab. 91(4), 1210–1217 (2006).
   PubMed Web of Science ®Google Scholar
• Levin L, Ban Y, Concepcion E, Davies TF, Greenberg DA, Tomer Y. Analysis of HLA genes in families with autoimmune diabetes and thyroiditis. Hum. Immunol. 65(6), 640–647 (2004)
   PubMed Web of Science ®Google Scholar
• Myhre AG, Undlien DE. Lovas K et al. Autoimmune adrenocortical failure in Norway: Autoantibodies and HLA class II associations related to clinical features. J. Clin. Endocrinol. Metab. 87(2), 618–623 (2002).
   PubMedGoogle Scholar
• Barker JM, Ide A, Hostetler C et al. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high risk population. J. Clin. Endocrinol. Metab. 90(1), 128–134 (2005).
   PubMedGoogle Scholar
• Norris JM, Barriga K, Hoffenberg EJ et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 293(19), 2343–2351 (2005).
   PubMed Web of Science ®Google Scholar
• Sollid LM. Breast milk against celiac disease. Gut 51(6), 767–768 (2002).
   PubMed Web of Science ®Google Scholar
• Ivarsson A, Hernell O, Stenlund H, Persson LA. Breast-feeding protects against celiac disease. Am. J. Clin. Nutr. 75(5), 914–921 (2002).
   PubMed Web of Science ®Google Scholar
• Agostoni C, Decsi T, Fewtrell M et al. ESPGHAN Committee on Nutrition. Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 46(1), 99–110 (2008).
   PubMed Web of Science ®Google Scholar
• Agostoni C, Braegger C, Decsi T et al. ESPGHAN Committee on Nutrition. Breastfeeding: A commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 49(1), 112–125 (2009).
   PubMed Web of Science ®Google Scholar
• Greer FR, Sicherer SH, Burks AW. American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Allergy and Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 121(1), 83–191 (2008).
   Web of Science ®Google Scholar
• EFSA Panel on Dietetic Products Nutrition and Allergies (NDA). Scientific opinion on the appropriate age for introduction of complementary feeding of infants. EFSA J. 7(12), 1423–1461 (2009)
   Google Scholar
• Nadal I, Donant E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J. Med. Microbiol. 56(12), 1669–1674 (2007).
   PubMed Web of Science ®Google Scholar
• Collado MC, Donat E,Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiology 8(232) (2008).
   PubMed Web of Science ®Google Scholar
• Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J. Clin. Pathol. 62(3), 264–269 (2009).
   PubMed Web of Science ®Google Scholar
• Sanchez E, De Palma G, Capilla A et al. Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species. Appl. Environ. Microbiol. 77(15), 5316–5323 (2011).
   PubMed Web of Science ®Google Scholar
• De Palma G, Capilla A, Nova E et al. Influence of milkfeeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: The PROFICEL study, PLoS ONE 7(2), e30791 (2012).
   PubMed Web of Science ®Google Scholar
• Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch. Dis. Child. 91(1), 39–43 (2006).
   PubMed Web of Science ®Google Scholar
• Giongo A, Gano KA, Crabb DB et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5(1), 82–91 (2010).
   PubMed Web of Science ®Google Scholar
• Lau K, Benitez P, Ardissone A et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J. Immunol. 186(6), 3538–3546 (2011).
   PubMedGoogle Scholar
• Hara N, Alkanani AK, Ir D et al. Prevention of virus-induced type 1 diabetes with antibiotic therapy. J. Immunol. 189(8), 3805–3814 (2012).
   PubMed Web of Science ®Google Scholar
• Kriegel MA, Sefik E, Hill JA, Wu H.J, Benoist C, Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in non-obese diabetic mice. Proc. Natl Acad. Sci. USA 108(28), 11548–11553 (2011).
   PubMed Web of Science ®Google Scholar
• Wen L, Ley RE, Volchkov PY et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455(7216), 1109–1113 (2008).
   PubMed Web of Science ®Google Scholar
• Atkinson M, Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 55(11), 2868–2877 (2012).
   PubMed Web of Science ®Google Scholar
• Zhou JS, Gill HS. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. Int. J. Food Microbiol. 103(1), 97–104 (2005).
   PubMed Web of Science ®Google Scholar
• Sasso FC, Carbonara O, Torella R et al. Ultrastructural changes in enterocytes in subjects with Hashimoto's thyroiditis. Gut 53(12), 1878–80 (2004)
   PubMed Web of Science ®Google Scholar
• Bethune MT, Khosla C. Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog. 4(2), e34, (2008).
   PubMedGoogle Scholar
• Bach JF. Infections and autoimmune diseases. J. Autoimmun. 25, 74–80 (2005).
   PubMed Web of Science ®Google Scholar
• Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat. Rev. Immunol. 9(12), 858–870 (2009).
   PubMed Web of Science ®Google Scholar
• Kagnoff M F, Paterson YJ, Kumar PJ et al. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 28(8), 995–1001 (1987).
   PubMed Web of Science ®Google Scholar
• Lindgren S, Sjoberg K, Eriksson S. Unsuspected coeliac disease in chronic “cryptogenic” liver disease. Scand. J. Gastroenterol. 29(7), 661–664 (1994).
   PubMed Web of Science ®Google Scholar
• Volta U, De Franceschi L, Molinaro N et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig. Dis. Sci. 43(10), 2190–2195 (1998).
   PubMed Web of Science ®Google Scholar
• Hernandez L, Johnson TC, Naiyer AJ et al. Chronic hepatitis C virus and celiac disease, is there an association? Dig. Dis. Sci. 53(1), 256–261 (2008).
   PubMed Web of Science ®Google Scholar
• Ruggeri C, La Masa AT, Rudi S et al. Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection. Dig. Dis. Sci. 53(8), 2151–2155 (2008).
   PubMed Web of Science ®Google Scholar
• Van Heel DA, Franke L, Hunt KA et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 39(7), 827–829 (2007).
   PubMed Web of Science ®Google Scholar
• Jabri B, Sollid LM. Mechanisms of disease: immunopathogenesis of celiac disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 3(9), 516–525 (2006).
   PubMedGoogle Scholar
• Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat. Rev. Immunol. 2(9), 647–655 (2002).
   PubMed Web of Science ®Google Scholar
• Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol. Rev. 206, 219–231 (2005).
   PubMed Web of Science ®Google Scholar
• Cinova J, Palovà-Jelinkovà L, Smythies LE et al. Gliadin peptides activate blood monocytes from patients with celiac disease. J. Clin. Immunol. 27(12), 201–209 (2007).
   PubMedGoogle Scholar
• Maiuri L, Ciacci C, Ricciardelli I et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362(9377), 30–37 (2003).
   PubMed Web of Science ®Google Scholar
• Palovà-Jelinkovà L, Rozkovà D, Pecharovà B et al. Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J. Immunol. 175(10), 7038–7045 (2005).
   PubMed Web of Science ®Google Scholar
• Tuckovà L, Novotnà J, Novàk P et al. Activation of macrophages by gliadin fragments: isolation and characterization of active peptide. J. Leukoc. Biol. 71(4), 625–631 (2002).
   PubMed Web of Science ®Google Scholar
• Thomas KE, Sapone A, Fasano A et al. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease. J. Immunol. 176(4), 2512–2521 (2006).
   PubMed Web of Science ®Google Scholar
• Meresse B. Cerf-Bensussan N. Innate T cell responses in human gut. Semin. Immunol. 21(3), 121–129 (2009).
   PubMedGoogle Scholar
• Di Sabatino A, Ciccocioppo R, Cupelli F et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55(4), 469–477 (2006).
   PubMed Web of Science ®Google Scholar
• Benahmed M, Meresse B, Arnulf B et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132(3), 994–1008 (2007).
   PubMedGoogle Scholar
• Bernardo D, Garrote JA, Allegretti Y et al. Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clin. Exp. Immunol. 154(1), 64–73 (2008).
   PubMedGoogle Scholar
• Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119(4), 996–1006 (2000).
   PubMedGoogle Scholar
• Vaarala O, Atkinson MA, Neu J. The ‘‘perfect storm’’ for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57(10), 2555–2562 (2008).
   PubMed Web of Science ®Google Scholar
• Honkanen J, Nieminen JK, Gao R et al. IL-17 immunity in human type 1 diabetes. J. Immunol. 185(3), 1959–1967 (2010).
   PubMed Web of Science ®Google Scholar
• Arif S, Moore F, Marks K et al. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated cell death. Diabetes 60(8), 2112–2119 (2011).
   PubMed Web of Science ®Google Scholar
• Mojibian M, Chakir H, Lefebvre DE et al. Diabetes specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes 58(8), 1789–1796 (2009).
   PubMed Web of Science ®Google Scholar
• Lammers KM, Lu R, Brownley J et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135(1), 194–204 (2008).
   PubMed Web of Science ®Google Scholar
• Heyman M, Abed J, Lebreton C, Cerf-Bensussan N. Intestinal permeability in celiac disease: insight into mechanisms and relevance to pathogenesis. Gut 61, 1355–1364 (2012).
   PubMed Web of Science ®Google Scholar
• Turley SJ, Lee JW, Dutton-Swain N, Mathis D, Benoist C. Endocrine self and gut nonself intersect in the pancreatic lymph nodes. Proc. Natl Acad. Sci. USA 102(49), 17729–17733 (2005).
   Google Scholar
• Hanninen A, Nurmela R, Maksimow M, Heino J, Jalkanen S, Kurts C. Islet beta-cell specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets. Am. J. Pathol. 170(1), 240–250 (2007).
   PubMed Web of Science ®Google Scholar
• Carratù R, Secondulfo M, de Magistris L et al. Altered intestinal permeability to mannitol in diabetes mellitus type I. J. Pediatr. Gastroenterol. Nutr. 28(3), 264–269 (1999).
   PubMed Web of Science ®Google Scholar
• Mooradian AD, Morley JE, Levine AS, Prigge WF, Gebhard RL. Abnormal intestinal permeability to sugars in diabetes mellitus. Diabetologia 29(4), 221–224 (1996).
   Web of Science ®Google Scholar
• Watts T, Berti I, Sapone A et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc. Natl Acad. Sci. USA 102(8), 2916–2921 (2005).
   Google Scholar
• Sapone A, de Magistris L, Pietzak M et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55(5), 1443–1449 (2006).
   PubMed Web of Science ®Google Scholar
• Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB. The safety, tolerance, pharmacokinetic and pharmacodynamics effects of single doses of AT-1001 in celiac disease subjects: a proof of concept study. Aliment. Pharmacol. Ther. 26(5), 757–766 (2007).
   PubMed Web of Science ®Google Scholar
• Hoffenberg EJ, McKenzie TL, Barriga KJ et al. A prospective study of the incidence of childhood celiac disease. J. Pediatr. 143(3), 308–314 (2003).
   PubMed Web of Science ®Google Scholar
• Maki M, Mustalahti K, Kokkonen J et al. Prevalence of Celiac disease among children in Finland. N. Engl. J. Med. 348, 2517–2524 (2003).
   PubMed Web of Science ®Google Scholar
• Peretti N, Bienvenu F, Bouvet C et al. The temporal relationship between the onset of type 1 diabetes and celiac disease: a study based on immunoglobulin A antitransglutaminase screening. Pediatrics 113(5), e418–e422 (2004).
   PubMedGoogle Scholar
• Karavanaki K, Kakleas K, Paschali E et al. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM). Horm. Res 71(4), 201–206 (2009).
   PubMed Web of Science ®Google Scholar
• Waisbourd-Zinman O, Hojsak I, Rosenbach Y et al. Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus. Dig. Dis. Sci. 57(5), 1314–1320 (2012).
   PubMedGoogle Scholar
• Cerutti F, Bruno G, Chiarelli F, Lorini R, Meschi F, Sacchetti C. Diabetes study group of the Italian Society of Pediatric Endocrinology and Diabetology. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Diabetes Care 27(6), 1294–1298 (2004).
   PubMed Web of Science ®Google Scholar
• Valerio G, Maiuri L, Troncone R et al. Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. Diabetologia 45(12), 1719–1722 (2002).
   PubMed Web of Science ®Google Scholar
• Camarca ME, Mozzillo E, Nugnes R et al. Celiac disease in type 1 diabetes mellitus. Ital. J. Pediatr. 38, 10 (2012).
   PubMedGoogle Scholar
• Rewers M, Liu E, Simmons J, Redondo MJ, Hoffenberg, EJ. Celiac disease associated with type 1 diabetes mellitus. Endocrinol. Metab. Clin. North Am. 33(1), 197–214 (2004).
   PubMed Web of Science ®Google Scholar
• Pocecco M, Ventura A. Coeliac disease and insulin-dependent diabetes mellitus: a causal association? Acta Paediatr. 84(12), 1432–1433 (1995).
   PubMedGoogle Scholar
• Kaspers S, Kordonouri O, Schober E, Grabert M, Hauffa BP, Holl RW. German Working Group for Pediatric Diabetology Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with celiac disease: A multicenter survey. J. Pediatr. 145(6), 790–795 (2004).
   PubMed Web of Science ®Google Scholar
• Norris JM, Barriga K, Klingensmith G et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 290(13), 1713–1720 (2003).
   PubMed Web of Science ®Google Scholar
• Schmid S, Buuck D, Knopff A, Bonifacio E, Ziegler AG. BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with type 1 diabetes by delaying exposure to gluten. Diabetologia 47(6), 1130–1131 (2004).
   PubMedGoogle Scholar
• Ventura A, Neri E, Ughi C, Leopaldi A, Citta A, Not T. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J. Pediatr. 137(2), 263–265 (2000).
   PubMed Web of Science ®Google Scholar
• Toscano V, Conti FG, Anastasi E et al. Importance of gluten in the induction of endocrine autoantibodies and organ dysfunction in adolescent celiac patients. Am. J. Gastroenterol. 95(7) (2000).
   PubMed Web of Science ®Google Scholar
• Hummel S, Pflüger M, Hummel M, Bonifacio E, Ziegler AG. Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care 34(6), 1301–1305 (2011).
   PubMed Web of Science ®Google Scholar
• Snell-Bergeon JK, Smith J, Dong F et al. Early childhood infections and the risk of islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Care 35(12), 2553–2558 (2012).
   PubMed Web of Science ®Google Scholar
• Pastore MR, Bazzigaluppi E, Belloni C, Arcovio C, Bonifacio E, Bosi E. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J. Clin. Endocrinol. Metab. 88(1), 162–165 (2003).
   PubMed Web of Science ®Google Scholar
• Fuchtenbusch M, Ziegler AG, Hummel M. Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev. Diabet. Stud. 1(1), 39–41 (2004).
   PubMedGoogle Scholar
• Ansaldi N, Palmas T, Corrias A et al. Autoimmune Thyroid Disease and Celiac Disease in Children. J. Pediatr. Gastroenterol. Nutr. 37, 63–66 (2003).
   PubMedGoogle Scholar
• Cassio A, Ricci G, Baronio F et al. Long-term clinical significance of thyroid autoimmunity in children with celiac disease. J. Pediatr. 156, 292–295 (2010).
   PubMed Web of Science ®Google Scholar
• Oderda G, Rapa A, Zavallone A, Strigini L, Bona G. Thyroid autoimmunity in childhood celiac disease. J. Pediatr. Gastroenterol. Nutr. 35, 704–705 (2002).
   PubMed Web of Science ®Google Scholar
• Meloni A, Mandas C, Jores RD, Congia M. Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J. Pediatr. 155, 51–55 (2009).
   PubMed Web of Science ®Google Scholar
• Diamanti A, Ferretti F, Guglielmi R et al. Thyroid autoimmunity in children with coeliac disease: a prospective survey. Arch. Dis. Child. 96, 1038–1041 (2011).
   PubMed Web of Science ®Google Scholar
• Valentino R, Savastano S, Tommaselli AP et al. Prevalence of coeliac disease in patients with thyroid autoimmunity. Horm. Res 51, 124–127 (1999).
   PubMed Web of Science ®Google Scholar
• Myhre AG, Aarsetøy H, Undlien DE, Hovdenak N, Aksnes L, Husebye ES. High frequency of coeliac disease among patients with autoimmune adrenocortical failure. Scand. J. Gastroenterol. 38(5), 511–515 (2003).
   PubMed Web of Science ®Google Scholar
• Elfström P, Montgomery SM, Kämpe O, Ekbom A, Ludvigsson JF. Risk of primary adrenal insufficiency in patients with celiac disease. J. Clin. Endocrinol. Metab. 92(9), 3595–3598 (2007).
   PubMed Web of Science ®Google Scholar
• O'Leary C, Walsh CH, Wieneke P et al. Coeliac disease and autoimmune Addison's disease: a clinical pitfall. QJM 95(2), 79–82 (2002).
   PubMed Web of Science ®Google Scholar
• Betterle C, Lazzarotto F, Spadaccino AC et al. Celiac disease in North Italian patients with autoimmune Addison's disease. Eur. J. Endocrinol. 154(2), 275–279 (2006).
   PubMedGoogle Scholar